In summary, the similar effects of gain and loss of function for both Sall4 and Bmi1 in AY-CCA suggest that BMI1 may act as a downstream effector of SALL4 in AY-CCA tumor development. This evidence concerns the gene SALL4 and cholangiocarcinoma.